Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

From PSA to Stockholm3, a Naturalistic Effectiveness Multipart Research Program: Study Part 1

NCT03381105 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT03381105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03381105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
From PSA to Stockholm3, a Naturalistic Effectiveness Multipart Research Program: Study Part 1
Lead sponsor
Helse Stavanger HF
Phase
Observational
Overall status
Active, not recruiting
Start date
September 1, 2017
Completion date
December 31, 2030
Enrollment
13,431 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer